Worth Venture Partners’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-39,000	Closed	-$198K	–	52
2024 Q1	$198K	Buy	+39,000	New	+$198K	1.32%	26
2019 Q2	–	Hold	0	–	–	–	87
2019 Q1	–	Hold	0	–	–	–	79
2017 Q1	–	Hold	0	–	–	–	108
2016 Q4	–	Hold	0	–	–	–	97